Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Aug;73(2):323-35.
doi: 10.1086/377139. Epub 2003 Jul 8.

Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2

Affiliations

Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2

Inga Reynisdottir et al. Am J Hum Genet. 2003 Aug.

Abstract

We report a genomewide linkage study of type 2 diabetes (T2D [MIM 125853]) in the Icelandic population. A list of type 2 diabetics was cross-matched with a computerized genealogical database clustering 763 type 2 diabetics into 227 families. The diabetic patients and their relatives were genotyped with 906 microsatellite markers. A nonparametric multipoint linkage analysis yielded linkage to 5q34-q35.2 (LOD = 2.90, P=1.29 x 10(-4)) in all diabetics. Since obesity, here defined as body mass index (BMI) > or =30 kg/m(2), is a key risk factor for the development of T2D, we studied the data either independently of BMI or by stratifying the patient group as obese (BMI > or =30) or nonobese (BMI <30). A nonparametric multipoint linkage analysis yielded linkage to 5q34-q35.2 (LOD = 3.64, P=2.12 x (10)-5) in the nonobese diabetics. No linkage was observed in this region for the obese diabetics. Linkage analysis conditioning on maternal transmission to the nonobese diabetics resulted in a LOD score of 3.48 (P=3.12 x 10(-5)) in the same region, whereas conditioning on paternal transmission led to a substantial drop in the LOD score. Finally, we observed potential interactions between the 5q locus and two T2D susceptibility loci, previously mapped in other populations.

PubMed Disclaimer

Figures

Figure  1
Figure 1
Genomewide scan using 906 microsatellite markers. Results are shown for three phenotypes: all type 2 diabetics (black lines), obese diabetics (red lines), and nonobese diabetics (blue lines). The multipoint LOD score is on the vertical axis, and the centiMorgan distance from the p-terminus of the chromosome is on the horizontal axis.
Figure  2
Figure 2
Multipoint allele-sharing LOD score of a portion of chromosome 5 after 38 microsatellite markers have been added to the framework marker set in a 40-cM interval from 160 cM to 200 cM. The average distance between the markers in the peak reagion is 0.84 cM. Results are shown for the same three phenotypes as in figure 1, and the location of the markers is indicated with green vertical bars at the top of the figure.
Figure  3
Figure 3
a, Positive interaction between the loci on chromosomes 5 and 12. Multipoint allele-sharing LOD score of a portion of chromosome 12 after 21 microsatellite markers have been added to the framework marker set. Results are shown for all nonobese diabetics (black line) and for nonobese diabetics in positive-NPL families on chromosome 5 (red line). b, Negative interaction between the loci on chromosomes 5 and 10. Multipoint allele-sharing LOD score of a portion of chromosome 10 after 8 microsatellite markers have been added to the framework marker set. Results are shown for all nonobese diabetics (black line) and for nonobese diabetics in negative-NPL families on chromosome 5 (blue line).
Figure  4
Figure 4
The effects of imprinting on the LOD score on chromosome 5. Maternal versus paternal effect on chromosome 5 locus. Results are shown for all nonobese diabetics (black line), nonobese diabetics with maternal inheritance (red line), and nonobese diabetics with paternal inheritance (blue line).

Similar articles

Cited by

References

Electronic-Database Information

    1. Cybergenetics, http://www.cybgen.com/ (for True Allele program)
    1. deCODE Genetics, http://www.decode.com/diabetes/markermaps/ (for marker maps in linkage analysis)
    1. International Obesity Task Force, http://www.iotf.org/
    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/
    1. UCSC Genome Bioinformatics, http://genome.ucsc.edu/

References

    1. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76–80 - PubMed
    1. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen GQ, Mott D, Knowler WC, Cox NJ, Horikawa Y, Oda N, Bell GI, Bogardus C (2000) A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106:R69–R73 - PMC - PubMed
    1. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM (1993) Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62–67 - PubMed
    1. Bray GA (1987) Overweight is risking fate. Definition, classification, prevalence, and risks. Ann N Y Acad Sci 499:14–28 - PubMed
    1. Busfield F, Duffy DL, Kesting JB, Walker SM, Lovelock PK, Good D, Tate H, Watego D, Marczak M, Hayman N, Shaw JT (2002) A genomewide search for type 2 diabetes-susceptibility genes in indigenous Australians. Am J Hum Genet 70:349–357 - PMC - PubMed

MeSH terms